# NIVF (Newgenivf Group Limited) - SEC EDGAR Financial Statements

> Newgenivf Group Limited reported $4.73M in revenue and net income of $9.88M for the fiscal year ended December 31, 2025 (down 13.0% year over year), with a 20.2% gross margin and a -226.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/NIVF
- Markdown: https://convexityos.com/fundamentals/NIVF.md
- SEC CIK: 0001981662
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001981662&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $4.73M | -13.0% YoY |
| Operating Income | FY 2025 | -$10.73M | -226.9% margin |
| Net Income | FY 2025 | $9.88M | 209.0% net margin |
| Diluted EPS | FY 2025 | $3.04 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$11.06M | -234.0% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $759K | Total debt: $510K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.73M | $5.43M | $5.14M | $5.94M | $4.12M |
| Cost of Revenue | $3.77M | $3.61M | $3.45M | $4.41M | $3.09M |
| **Gross Profit** | $956K | $1.83M | $1.68M | $1.54M | $1.02M |
| Selling, General & Admin | $11.68M | $2.99M | $1.64M | $1.14M | $826K |
| Total Operating Expenses | $11.68M | $2.99M | $1.64M | $1.14M | $826K |
| **Operating Income** | -$10.73M | -$1.16M | $42K | $399K | $199K |
| **EBITDA** | -$10.54M | -$1.14M | $73K | $499K | $365K |
| Interest Income | $2.3K | $7.0K | $518 | $21 | $63 |
| Interest Expense | $616K | $765K | $46K | -- | -- |
| Income Before Tax | $9.73M | -$961K | $108K | $344K | $156K |
| Income Tax Expense | -- | -$487K | -- | $208K | $295K |
| **Net Income** | $9.88M | -$525K | $130K | $459K | -$533 |
| Basic EPS | $214.73 | -$4,408.76 | $13,019.30 | $78,666,666.67 | $0.00 |
| **Diluted EPS** | $3.04 | -$4,408.76 | $13,019.30 | $78,666,666.67 | $0.00 |
| Basic Shares Outstanding | 46.0K | 119 | 10 | 0 | 0 |
| Diluted Shares Outstanding | 3.3M | 119 | 10 | 0 | 0 |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $759K | $458K | $54K | $28K |
| **Cash & Short-Term Investments** | $759K | $458K | $54K | $28K |
| Accounts Receivable, Net | $167K | $49K | $9.4K | $13K |
| Inventory | $335K | $81K | $126K | $47K |
| **Total Current Assets** | $7.38M | $3.17M | $2.46M | $2.40M |
| Property, Plant & Equipment, Net | $1.79M | $273K | $162K | $123K |
| Intangible Assets | $21.42M | -- | -- | -- |
| **Total Non-Current Assets** | $25.34M | $405K | $2.03M | $506K |
| **Total Assets** | $32.72M | $3.58M | $4.49M | $2.90M |
| Accounts Payable | $779K | $1.30M | $173K | $105K |
| Deferred Revenue (Current) | $112K | $63K | $7.9K | $1.36M |
| **Total Current Liabilities** | $2.37M | $2.72M | $1.12M | $2.56M |
| **Total Non-Current Liabilities** | $4.37M | $2.34M | $119K | $249K |
| **Total Liabilities** | $6.74M | $5.06M | $1.24M | $2.80M |
| **Total Debt (incl. Leases)** | $510K | $119K | $652K | $854K |
| Common Stock | -- | -- | $7.0K | $6.0K |
| Retained Earnings | $8.89M | -$986K | -$461K | -$592K |
| Accumulated Other Comp. Income | -$143K | $19K | -$7.3K | $9.6K |
| **Total Stockholders' Equity** | $26.63M | -$1.05M | $3.74M | $563K |
| Total Equity | $25.99M | -$1.48M | $3.25M | $101K |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $759K | $458K | $54K | $28K |
| **Cash & Short-Term Investments** | $759K | $458K | $54K | $28K |
| Accounts Receivable, Net | $167K | $49K | $9.4K | $13K |
| Inventory | $335K | $81K | $126K | $47K |
| **Total Current Assets** | $7.38M | $3.17M | $2.46M | $2.40M |
| Property, Plant & Equipment, Net | $1.79M | $273K | $162K | $123K |
| Intangible Assets | $21.42M | -- | -- | -- |
| **Total Non-Current Assets** | $25.34M | $405K | $2.03M | $506K |
| **Total Assets** | $32.72M | $3.58M | $4.49M | $2.90M |
| Accounts Payable | $779K | $1.30M | $173K | $105K |
| Deferred Revenue (Current) | $112K | $63K | $7.9K | $1.36M |
| **Total Current Liabilities** | $2.37M | $2.72M | $1.12M | $2.56M |
| **Total Non-Current Liabilities** | $4.37M | $2.34M | $119K | $249K |
| **Total Liabilities** | $6.74M | $5.06M | $1.24M | $2.80M |
| **Total Debt (incl. Leases)** | $510K | $119K | $652K | $854K |
| Common Stock | -- | -- | $7.0K | $6.0K |
| Retained Earnings | $8.89M | -$986K | -$461K | -$592K |
| Accumulated Other Comp. Income | -$143K | $19K | -$7.3K | $9.6K |
| **Total Stockholders' Equity** | $26.63M | -$1.05M | $3.74M | $563K |
| Total Equity | $25.99M | -$1.48M | $3.25M | $101K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | $9.73M | -$474K | $108K | $136K | -$139K |
| Depreciation & Amortization | $188K | $20K | $31K | $101K | $167K |
| Stock-Based Compensation | -- | -- | -- | $240K | $200K |
| Change in Receivables | -$117K | -$40K | $1.2K | $130K | $56K |
| Change in Inventory | -$255K | $45K | -$81K | -$7.2K | $1.4K |
| Change in Payables | -$520K | $1.13M | $71K | $59K | -$61K |
| **Operating Cash Flow** | -$10.93M | -$8.26M | -$1.77M | $1.71M | $1.43M |
| Capital Expenditure | -$135K | -$53K | -$70K | -$94K | -$17K |
| **Free Cash Flow** | -$11.06M | -$8.32M | -$1.84M | $1.62M | $1.42M |
| **Investing Cash Flow** | -$7.56M | -$53K | -$70K | -$94K | -$17K |
| Common Stock Issued | $12.62M | -- | $192K | -- | -- |
| **Financing Cash Flow** | $18.99M | $8.68M | $1.88M | -$1.63M | -$1.54M |
| **Net Change in Cash** | $507K | $359K | $46K | -$17K | -$128K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 20.2% | 33.6% | 32.7% | 25.9% | 24.9% |
| **Operating Margin** | -226.9% | -21.4% | 0.8% | 6.7% | 4.8% |
| **Net Profit Margin** | 209.0% | -9.7% | 2.5% | 7.7% | 0.0% |
| Return on Equity (ROE) | 37.1% | -- | 3.5% | 81.5% | -- |
| Return on Assets (ROA) | 30.2% | -14.7% | 2.9% | 15.8% | -- |
| Current Ratio | 3.12x | 1.17x | 2.19x | 0.94x | -- |
| Quick Ratio | 2.98x | 1.14x | 2.08x | 0.92x | -- |
| Debt to Equity | 0.02x | -- | 0.17x | 1.52x | -- |
| **Revenue Growth (YoY)** | -13.0% | +5.8% | -13.6% | +44.3% | -- |
| Gross Profit Growth (YoY) | -47.7% | +8.6% | +9.4% | +50.1% | -- |
| Operating Income Growth (YoY) | -- | -2847.3% | -89.4% | +100.6% | -- |
| **Net Income Growth (YoY)** | -- | -503.0% | -71.6% | -- | -- |
| EPS Growth (YoY) | -- | -133.9% | -100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -203.2% | +19.4% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -213.6% | +14.1% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
